Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes
<p>Abstract</p> <p>Background</p> <p>Analyzing drop out rates and when they occur may give important information about the patient characteristics and trial characteristics that affect the overall uptake of an intervention.</p> <p>Methods</p> <p>...
Main Authors: | Fitzmaurice David, Ward A Alison, Perera Rafael, Heneghan Carl, Meats Emma, Glasziou Paul |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-05-01
|
Series: | BMC Medical Research Methodology |
Online Access: | http://www.biomedcentral.com/1471-2288/7/18 |
Similar Items
-
Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes
by: Heneghan, C, et al.
Published: (2007) -
Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetes.
by: Heneghan, C, et al.
Published: (2007) -
Self-monitoring and self-management of oral anticoagulation
by: Josep M Garcia-Alamino, et al. -
Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.
by: Heneghan, C, et al.
Published: (2006) -
Self-monitoring and self-management of oral anticoagulation.
by: Garcia-Alamino, J, et al.
Published: (2010)